199 related articles for article (PubMed ID: 2120588)
1. Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study Group.
Busch MP; Taylor PE; Lenes BA; Kleinman SH; Stuart M; Stevens CE; Tomasulo PA; Allain JP; Hollingsworth CG; Mosley JW
N Engl J Med; 1990 Nov; 323(19):1308-12. PubMed ID: 2120588
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group.
Alter HJ; Epstein JS; Swenson SG; VanRaden MJ; Ward JW; Kaslow RA; Menitove JE; Klein HG; Sandler SG; Sayers MH
N Engl J Med; 1990 Nov; 323(19):1312-7. PubMed ID: 2120589
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
4. Plasma viremia in human immunodeficiency virus infection.
Coombs RW; Collier AC; Allain JP; Nikora B; Leuther M; Gjerset GF; Corey L
N Engl J Med; 1989 Dec; 321(24):1626-31. PubMed ID: 2511447
[TBL] [Abstract][Full Text] [Related]
5. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
[TBL] [Abstract][Full Text] [Related]
6. Markers of human immunodeficiency virus infection in high-risk individuals seronegative by first generation enzyme-linked immunosorbent assay.
Pedersen C; Lindhardt BO; Lauritzen E; Gaub J; Dickmeiss E
Dan Med Bull; 1989 Oct; 36(5):490-1. PubMed ID: 2509148
[TBL] [Abstract][Full Text] [Related]
7. Transfusion-associated human immunodeficiency virus type 1 from screened antibody-negative blood donors.
Roberts CR; Longfield JN; Platte RC; Zielmanski KP; Wages J; Fowler A
Arch Pathol Lab Med; 1994 Dec; 118(12):1188-92. PubMed ID: 7979912
[TBL] [Abstract][Full Text] [Related]
8. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia].
Kopecká D; Brůcková M; Stanková M; Syrůcek L; Vojtĕchovský K; Petkov V
Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):65-73. PubMed ID: 2142624
[TBL] [Abstract][Full Text] [Related]
9. HIV-p24-antigen-bearing macrophages are only present in brains of HIV-seropositive patients with AIDS-encephalopathy.
Schindelmeiser J; Gullotta F
Clin Neuropathol; 1991; 10(3):109-11. PubMed ID: 1907231
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil.
Barreto CC; Sabino EC; Gonçalez TT; Laycock ME; Pappalardo BL; Salles NA; Wright DJ; Chamone DF; Busch MP
Transfusion; 2005 Nov; 45(11):1709-14. PubMed ID: 16271094
[TBL] [Abstract][Full Text] [Related]
11. Infectious disease markers in blood donors in northern Thailand.
Mundee Y; Kamtorn N; Chaiyaphruk S; Nantachit N; Ness PM; Nelson KE
Transfusion; 1995 Mar; 35(3):264-7. PubMed ID: 7878721
[TBL] [Abstract][Full Text] [Related]
12. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM
AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904
[TBL] [Abstract][Full Text] [Related]
13. [HIV antigen test of blood donors].
Knödler B; Kühnl P
Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():10-1. PubMed ID: 8374280
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations.
Benjamin RJ; Busch MP; Fang CT; Notari EP; Puren A; Schoub BD; Tobler LH; Hogrefe W; du P Heyns A; Stramer SL; Crookes RL
Transfusion; 2008 Feb; 48(2):295-303. PubMed ID: 18005322
[TBL] [Abstract][Full Text] [Related]
15. U.S. Public Health Service guidelines for testing and counseling blood and plasma donors for human immunodeficiency virus type 1 antigen.
MMWR Recomm Rep; 1996 Mar; 45(RR-2):1-9. PubMed ID: 8604210
[TBL] [Abstract][Full Text] [Related]
16. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia.
MacDonell KB; Chmiel JS; Poggensee L; Wu S; Phair JP
Am J Med; 1990 Dec; 89(6):706-12. PubMed ID: 1979205
[TBL] [Abstract][Full Text] [Related]
17. Relationship between human immunodeficiency virus antigenemia and cytomegalovirus infection.
Lazzarotto T; Guan MX; Furlini G; Re MC; Ripalti A; Landini MP; La Placa M
Microbiologica; 1990 Jan; 13(1):61-5. PubMed ID: 2155377
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 infection of endothelial cells in vitro.
Re MC; Furlini G; Cenacchi G; Preda P; La Placa M
Microbiologica; 1991 Apr; 14(2):149-52. PubMed ID: 1713288
[TBL] [Abstract][Full Text] [Related]
19. p24 antigen screening to reduce the risk of HIV transmission by seronegative bone allograft donors.
Malhotra R; Morgan DA
Natl Med J India; 2000; 13(4):190-2. PubMed ID: 11002686
[TBL] [Abstract][Full Text] [Related]
20. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
